Ivermectin

CAS 70288-86-7 8 FDA-DMF suppliersSmall Molecule

Overview

Ivermectin is an antiparasitic agent used to treat several parasitic infestations. It works by binding to glutamate-gated chloride channels, causing paralysis and death of the parasite.

API suppliers (6)

Suppliers of Ivermectin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • HOVIONE PHARMASCIENCE LTD1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • HOVIONE PHARMASCIENCE LTD1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
  • SHANGHAI TONGREN PHARMACEUTICAL CO LTD
  • DELTA TECH LTD

Patent & exclusivity (US)

Per the FDA Orange Book (15 approved US products), the latest listed US patent on Ivermectin expires 13 Mar 2034. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

AntiparasiticDermatology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.